Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1025-1030

  Soini, Y ^a   Virkajarvi N ^a   Lehto, V P ^a   Paakko P ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Apoptosis; Liver carcinoma; p53

Indexed keywords

CYCLINE; PROTEIN BCL 2; PROTEIN P53;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL DEATH; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; STAINING;

EID: 0029987762     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.199     Document Type: Article

References (20)

1. CHARLOTTE R, L'HERMAINE A, MARTIN N, GELEYN Y, NOLLET M, GAULARD P AND ZAFRANI S. (1994). Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am. J. Pathol., 144, 460-465.
2. COLLIER JD, CARPENTER M, BURT AD AND BASSENDINE MF. (1994). Expression of mutant p53 protein in hepatocellular carcinoma. Gut, 35, 98-100.
3. EDMONDSON HA AND STEINER PE. (1954). Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer, 7, 462-503.
4. GIBSON JB AND SOBIN LH. (1978). Histological Typing of Tumours of the Liver, Biliary Tract and Pancreas, International Histological Classification of Tumours No 20. World Health Organization: Geneva.
5. GREENBLATT MS, BENNETT WP, HOLLSTEIN M AND HARRIS CC. (1994). Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res., 55, 4855-4878.
6. HALDAR S, NEGRINI M, MONNA M, SABBIONI S AND GROCE C. (1994). Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54, 2095-2097.
7. HOCKENBERRY DM. (1994). Bcl-2 in cancer, development and apoptosis. J. Cell Sci., 18, 51-55.
8. LANE DP. (1992). p53, guardian of the genome. Nature, 358, 15-16.
9. LAURENT-PUIG P, FLEJOU JF, FABRE M, BEDOSSA P, BELGHITI J, GAYRAL F AND FRANCO D. (1992). Overexpression of p53: a rare event in a large series of white patients with hepatocellular carcinoma. Hepatology, 16, 1171-1175.
10. MIYASHITA T AND REED JC. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
11. MIYASHITA T, KRAJEWSKI S, KRAJEWSKI M, WANG HG, LIN HK, LIEBERMANN DA, HOFFMAN B AND REED JC. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
12. REED JC. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol., 124, 1-6.
13. SOINI Y, PÄÄKKÖ P, NUORVA K, KAMEL D, LANE D AND VÄHÄKANGAS K. (1992). Comparative analysis of p53 protein-immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch. A., 421, 223-228.
14. SPIESSL B, BEAHRS OH, HERMANEK P, HUTTER RVP, SCHEIBE O, SOBIN LH AND WAGNER G. (1992). TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 3rd edn., International Union Against Cancer. Springer: Berlin.
15. STEEL GG. (1977). Growth kinetics of tumours, pp. 56-85. Oxford University Press: Oxford.
16. TÖRMÄNEN U, EEROLA A-K, RAINIO P, VÄHÄKANGAS K, SOINI Y, SORMUNEN R, BLOIGU R, LEHTO V-P AND PÄÄKKÖ P. (1995). Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res., 55, 5595-5602.
17. TSUJIMOTO Y, COSSMAN J, JAFFE E AND CROCE C. (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443.
18. VOLKMANN M, HOFFMANN WJ, MULLER M, RATH U, OTTO G, ZENTGRAF H AND GALLE PR. (1994). p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene, 9, 195-204.
19. WANDS JR AND BLUM HE (1991). Primary hepatocellular carcinoma. N. Engl. J. Med., 325, 729-731.
20. YOUNISH-ROUACH E, RESNITZKY D, LOTEM J, SACHS L, KIMCHI A AND OREN M. (1991). Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.